GB0612428D0 - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
GB0612428D0
GB0612428D0 GBGB0612428.3A GB0612428A GB0612428D0 GB 0612428 D0 GB0612428 D0 GB 0612428D0 GB 0612428 A GB0612428 A GB 0612428A GB 0612428 D0 GB0612428 D0 GB 0612428D0
Authority
GB
United Kingdom
Prior art keywords
antibacterial agents
antibacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0612428.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prolysis Ltd
Original Assignee
Prolysis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolysis Ltd filed Critical Prolysis Ltd
Priority to GBGB0612428.3A priority Critical patent/GB0612428D0/en
Publication of GB0612428D0 publication Critical patent/GB0612428D0/en
Priority to EP20070733310 priority patent/EP2034997B1/en
Priority to US12/304,303 priority patent/US7977340B2/en
Priority to AU2007262791A priority patent/AU2007262791B2/en
Priority to PCT/GB2007/002314 priority patent/WO2007148093A1/en
Priority to SG2011040847A priority patent/SG172676A1/en
Priority to ES07733310T priority patent/ES2403005T3/es
Priority to CA2655403A priority patent/CA2655403C/en
Priority to DK07733310T priority patent/DK2034997T3/da
Priority to PT07733310T priority patent/PT2034997E/pt
Priority to BRPI0713501-7A priority patent/BRPI0713501A2/pt
Priority to JP2009515958A priority patent/JP5309021B2/ja
Priority to CN200780023251XA priority patent/CN101472585B/zh
Priority to NZ574313A priority patent/NZ574313A/en
Priority to PL07733310T priority patent/PL2034997T3/pl
Priority to EA200900047A priority patent/EA019748B1/ru
Priority to MX2008015706A priority patent/MX2008015706A/es
Priority to KR1020097001499A priority patent/KR101443795B1/ko
Priority to MYPI20085070 priority patent/MY148682A/en
Priority to IL195687A priority patent/IL195687A/en
Priority to ZA2009/00240A priority patent/ZA200900240B/en
Priority to US13/154,485 priority patent/US8481544B2/en
Priority to US13/154,592 priority patent/US8389516B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB0612428.3A 2006-06-22 2006-06-22 Antibacterial agents Ceased GB0612428D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB0612428.3A GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents
MYPI20085070 MY148682A (en) 2006-06-22 2007-06-21 Antibacterial compositions
BRPI0713501-7A BRPI0713501A2 (pt) 2006-06-22 2007-06-21 composições antibacterianas
CN200780023251XA CN101472585B (zh) 2006-06-22 2007-06-21 抗菌组合物
AU2007262791A AU2007262791B2 (en) 2006-06-22 2007-06-21 Antibacterial compositions
PCT/GB2007/002314 WO2007148093A1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
SG2011040847A SG172676A1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
ES07733310T ES2403005T3 (es) 2006-06-22 2007-06-21 Composiciones antibacterianas
CA2655403A CA2655403C (en) 2006-06-22 2007-06-21 Antibacterial benzothiazoles and thiazolopyridines
DK07733310T DK2034997T3 (da) 2006-06-22 2007-06-21 Antibakterielle sammensætninger
PT07733310T PT2034997E (pt) 2006-06-22 2007-06-21 Composições antibacterianas
EP20070733310 EP2034997B1 (en) 2006-06-22 2007-06-21 Antibacterial compositions
JP2009515958A JP5309021B2 (ja) 2006-06-22 2007-06-21 抗菌組成物
US12/304,303 US7977340B2 (en) 2006-06-22 2007-06-21 Antibacterial compositions
NZ574313A NZ574313A (en) 2006-06-22 2007-06-21 Antibacterial compositions
PL07733310T PL2034997T3 (pl) 2006-06-22 2007-06-21 Kompozycje przeciwbakteryjne
EA200900047A EA019748B1 (ru) 2006-06-22 2007-06-21 Антибактериальные композиции
MX2008015706A MX2008015706A (es) 2006-06-22 2007-06-21 Composiciones antibacterianas.
KR1020097001499A KR101443795B1 (ko) 2006-06-22 2007-06-21 항균성 조성물
IL195687A IL195687A (en) 2006-06-22 2008-12-03 Benzo-thiazole and thiazolo-pyridine for use in the treatment of bacterial infections
ZA2009/00240A ZA200900240B (en) 2006-06-22 2009-01-12 Antibacterial compositions
US13/154,485 US8481544B2 (en) 2006-06-22 2011-06-07 Antibacterial compositions
US13/154,592 US8389516B2 (en) 2006-06-22 2011-06-07 Antibacterial compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0612428.3A GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents

Publications (1)

Publication Number Publication Date
GB0612428D0 true GB0612428D0 (en) 2006-08-02

Family

ID=36803739

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0612428.3A Ceased GB0612428D0 (en) 2006-06-22 2006-06-22 Antibacterial agents

Country Status (21)

Country Link
US (2) US7977340B2 (enExample)
EP (1) EP2034997B1 (enExample)
JP (1) JP5309021B2 (enExample)
KR (1) KR101443795B1 (enExample)
CN (1) CN101472585B (enExample)
AU (1) AU2007262791B2 (enExample)
BR (1) BRPI0713501A2 (enExample)
CA (1) CA2655403C (enExample)
DK (1) DK2034997T3 (enExample)
EA (1) EA019748B1 (enExample)
ES (1) ES2403005T3 (enExample)
GB (1) GB0612428D0 (enExample)
IL (1) IL195687A (enExample)
MX (1) MX2008015706A (enExample)
MY (1) MY148682A (enExample)
NZ (1) NZ574313A (enExample)
PL (1) PL2034997T3 (enExample)
PT (1) PT2034997E (enExample)
SG (1) SG172676A1 (enExample)
WO (1) WO2007148093A1 (enExample)
ZA (1) ZA200900240B (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0612428D0 (en) 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents
US8481544B2 (en) 2006-06-22 2013-07-09 Biota Europe Limited Antibacterial compositions
GB0724349D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Antibacterial agents
WO2008068470A1 (en) 2006-12-04 2008-06-12 Astrazeneca Ab Antibacterial polycyclic urea compounds
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン， インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
US20110166088A1 (en) * 2008-06-25 2011-07-07 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
EP2277870A1 (de) * 2009-06-24 2011-01-26 Bayer CropScience AG Substituierte Benzoxa(thia)zole
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
EP2552893B1 (en) 2010-03-31 2014-10-29 Actelion Pharmaceuticals Ltd. Antibacterial isoquinolin-3-ylurea derivatives
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
HRP20160397T1 (hr) 2010-06-01 2016-08-12 Summit Therapeutics Plc Spojevi za liječenje clostridium difficile povezanih bolesti
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
JP6085829B2 (ja) 2011-01-14 2017-03-01 スペロ トリネム， インコーポレイテッド ピリミジンジャイレースおよびトポイソメラーゼｉｖ阻害剤
PT2663556E (pt) 2011-01-14 2014-11-27 Vertex Pharma Processo de fabrico de inibidores de girase e topoisomerase iv
EP2663558A1 (en) 2011-01-14 2013-11-20 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
RU2625305C2 (ru) 2011-01-14 2017-07-13 Сперо Тринем, Инк. Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
WO2012177707A1 (en) 2011-06-20 2012-12-27 Vertex Pharmaceuticals Incorporated Phosphate esters of gyrase and topoisomerase inhibitors
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013235038A1 (en) 2012-03-21 2014-10-09 Malvika Kaul Antimicrobial agents
WO2013138860A1 (en) 2012-03-22 2013-09-26 Biota Europe Limited Antibacterial compounds
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014087431A1 (en) * 2012-12-09 2014-06-12 Council Of Scientific & Industrial Research One pot process for the conversion of aroyl chlorides to acyl thioureas
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
EP3102203A2 (en) 2014-02-03 2016-12-14 Spero Gyrase, Inc. Antibacterial combinations comprising polymyxin
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones
BR112017011791A2 (pt) * 2014-12-02 2018-02-27 Bayer Cropscience Aktiengesellschaft compostos bicíclicos como agentes de controle de pragas
WO2016127102A2 (en) 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
AR104259A1 (es) * 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
CN106167486B (zh) * 2015-05-22 2019-06-14 北京四环制药有限公司 单环类回旋酶和拓扑异构酶iv抑制剂
CN109195957A (zh) 2016-02-25 2019-01-11 塔克西斯医药股份有限公司 合成方法和中间体
AU2018208422B2 (en) 2017-01-10 2021-11-11 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
US20210070747A1 (en) 2017-03-24 2021-03-11 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates towardthe production of txa709
TWI820231B (zh) 2018-10-11 2023-11-01 德商拜耳廠股份有限公司 用於製備經取代咪唑衍生物之方法
MX2022000598A (es) 2019-07-17 2022-03-04 Summit Oxford Ltd Preparacion de compuestos antibacterianos.
US20230247994A1 (en) 2020-07-02 2023-08-10 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
US12220421B2 (en) 2021-09-09 2025-02-11 The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Inhibitors of C. difficile spore germination
CN116444376B (zh) * 2023-04-19 2024-01-26 德兴市德邦化工有限公司 一种3,5-二氯硝基苯的生产工艺
WO2025026738A1 (en) 2023-07-31 2025-02-06 Bayer Aktiengesellschaft 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides
WO2026015823A1 (en) * 2024-07-11 2026-01-15 Purdue Research Foundation Bacterial carbonic anhydrase inhibitors with improved pharmacokinetics and efficacy
CN119350937B (zh) * 2024-10-30 2025-08-12 广东豪之盛新材料有限公司 一种双组份气雾喷漆及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810988A (en) * 1968-11-01 1974-05-14 Ciba Geigy Ag Control of phytopathogenic fungi with n-benzothiazae-2-yl n-{40 {11 propylure
CH505543A (de) 1968-11-01 1971-04-15 Ciba Geigy Ag Schädlingsbekämpfungsmittel
US4028374A (en) * 1975-11-03 1977-06-07 Morton-Norwich Products, Inc. Antibacterial thiocyanatobenzothiazoles
WO2001057008A1 (en) * 2000-02-07 2001-08-09 Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
NZ522928A (en) * 2000-06-21 2005-05-27 F Benzothiazole derivatives
MY138797A (en) * 2000-12-15 2009-07-31 Vertex Pharma Bacterial gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
WO2005037845A1 (en) * 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
KR20070106969A (ko) * 2004-09-09 2007-11-06 추가이 세이야쿠 가부시키가이샤 신규 이미다졸리딘 유도체 및 그 용도
GB0612428D0 (en) 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents

Also Published As

Publication number Publication date
MY148682A (en) 2013-05-31
DK2034997T3 (da) 2013-02-11
AU2007262791B2 (en) 2012-11-08
KR20090029817A (ko) 2009-03-23
PT2034997E (pt) 2013-01-24
ES2403005T3 (es) 2013-05-13
EA019748B1 (ru) 2014-06-30
JP2009541289A (ja) 2009-11-26
US7977340B2 (en) 2011-07-12
BRPI0713501A2 (pt) 2012-03-13
KR101443795B1 (ko) 2014-10-21
US20110263590A1 (en) 2011-10-27
EP2034997B1 (en) 2012-10-17
CN101472585B (zh) 2013-12-04
US8389516B2 (en) 2013-03-05
SG172676A1 (en) 2011-07-28
ZA200900240B (en) 2009-12-30
WO2007148093A1 (en) 2007-12-27
NZ574313A (en) 2011-10-28
IL195687A0 (en) 2009-09-01
CA2655403C (en) 2014-02-04
EA200900047A1 (ru) 2009-06-30
US20090197877A1 (en) 2009-08-06
AU2007262791A1 (en) 2007-12-27
JP5309021B2 (ja) 2013-10-09
IL195687A (en) 2013-12-31
PL2034997T3 (pl) 2013-04-30
EP2034997A1 (en) 2009-03-18
CN101472585A (zh) 2009-07-01
CA2655403A1 (en) 2007-12-27
MX2008015706A (es) 2009-03-31

Similar Documents

Publication Publication Date Title
GB0724349D0 (en) Antibacterial agents
ZA200900240B (en) Antibacterial compositions
GB0724278D0 (en) uses for antimicrobial agents
IL196865A0 (en) Antimicrobials
EP2007377A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
GB0815484D0 (en) Antibacterial agents
IL202487A0 (en) Contrast agents
GB0718735D0 (en) Antibacterial agents
IL185899A0 (en) Antibacterial amide-macrocycles v
ZA200903041B (en) Combination
GB0601687D0 (en) Antimicrobial materials
EP1988901A4 (en) Ceacam based antibacterial agents
EP1846411A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
ZA200808035B (en) Antibacterial agents
EP1846417A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
EP1846418A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCES
EP1845995A4 (en) ANTIBACTERIAL AGENTS
EP1846416A4 (en) ANTIBACTERIAL AGENTS
GB0609530D0 (en) Combination
GB0609619D0 (en) Combination
ZA200809821B (en) Novel antibacterial compounds
EP1962864A4 (en) ANTIBACTERIAL AGENTS
GB0718023D0 (en) Anti-bacterial agents
GB0623070D0 (en) Antibacterial agents
GB0718738D0 (en) Antibacterial agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)